Akoya Biosciences(AKYA) - 2025 Q1 - Quarterly Results

Exhibit 99.1 First Quarter 2025 Business Highlights ● Revenue was $16.6 million in the first quarter of 2025, compared to $18.4 million in the prior year period; a decrease of 9.8%. ● Gross margin was 59.3% in the first quarter of 2025, compared to 45.7% in the prior year period. ● Operating expenses were $23.3 million for the first quarter of 2025, compared to $30.0 million in the prior year period, an improvement of 22.3%. ● Operating loss was $13.4 million for the first quarter of 2025, compared to $21.6 ...